KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Cash from Financing Activities (2016 - 2025)

Medpace Holdings' Cash from Financing Activities history spans 11 years, with the latest figure at $22.7 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 113.48% year-over-year to $22.7 million; the TTM value through Dec 2025 reached -$860.4 million, down 458.66%, while the annual FY2025 figure was -$860.4 million, 458.66% down from the prior year.
  • Cash from Financing Activities reached $22.7 million in Q4 2025 per MEDP's latest filing, up from $3.4 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $22.7 million in Q4 2025 to a low of -$540.6 million in Q2 2025.
  • Average Cash from Financing Activities over 5 years is -$100.9 million, with a median of -$50.0 million recorded in 2021.
  • Peak YoY movement for Cash from Financing Activities: surged 122.5% in 2021, then plummeted 81265.77% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $2.4 million in 2021, then crashed by 5493.71% to -$131.1 million in 2022, then surged by 101.16% to $1.5 million in 2023, then crashed by 11170.85% to -$168.6 million in 2024, then soared by 113.48% to $22.7 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Cash from Financing Activities are $22.7 million (Q4 2025), $3.4 million (Q3 2025), and -$540.6 million (Q2 2025).